Identification of CARS-ALK Fusion in Primary and Metastatic Lesions of an Inflammatory Myofibroblastic Tumor-Reference-Cited by-同舟云学术

Identification of CARS-ALK Fusion in Primary and Metastatic Lesions of an Inflammatory Myofibroblastic Tumor

Published:2003-09 Issue:9 Volume:83 Page:1255-1265
ISSN:0023-6837
Container-title:Laboratory Investigation
language:
Short-container-title:Lab Invest

Author:

Debelenko Larisa V,Arthur Diane C,Pack Svetlana D,Helman Lee J,Schrump David S,Tsokos Maria

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Reference46 articles.

1. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

2. Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor

3. Expression of ALK1 and p80 in Inflammatory Myofibroblastic Tumor and Its Mesenchymal Mimics: A Study of 135 Cases

4. Coffin CM, Fletcher JA and. 2002 Inflammatory myofibroblastic tumor. (In: Fletcher CDM, Unni KK) (and) (Mertens F) (editors) Pathology and genetics of tumors of soft tissue and bone Lyon: IARC Press 91–93.

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of orally bioavailable ALK PROTACs based Ceritinib against ALK positive cancers;European Journal of Medicinal Chemistry;2024-09

2. Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line;Human Cell;2024-05-16

3. Insight into systematic development of ALK (anaplastic lymphoma kinase) inhibitors towards NSCLC treatment;European Journal of Medicinal Chemistry Reports;2024-04

4. Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment;Oncology Research;2024

5. Individualized targeted treatment in a case of a rare TFG::ROS1 fusion positive inflammatory myofibroblastic tumor (IMT);Cancer Reports;2023-11-11